Schisandra: benefits, dosage, contraindications
Other name(s)
Peruvian maca, Peruvian ginseng, Peruvian maca
Scientific name(s)
Schisandra chinensis, Kadsura chinensis
Family or group:
Plants
Active ingredients:
Schizandrin
Vitamin C
Vitamin E
Lignans
Indications
Scoring methodology
EFSA approval.
Cognitive performance ✪✪✪✪✪
A randomized, double-blind, placebo-controlled study evaluated the effect of a single dose (270 mg) of a standardized combination of Schisandra, Rhodiola, and Eleutherococcus on cognitive function in 40 healthy women aged 20 to 68. Two hours after treatment, the group that received the treatment showed improved attention, increased speed and accuracy when performing stressful cognitive tasks compared with controls.
Posologie
Synergies
Respiratory infections ✪✪✪✪✪
A randomized, double-blind, placebo-controlled pilot study examined the effects of a preparation containing 51.0% Schisandra, 27.6% Rhodiola, and 24.4% Eleutherococcus on recovery time and quality of life scores in patients with unspecified acute pneumonia. Sixty participants were randomized to receive the standard treatment of cephazolin, bromhexine, and theophylline or the standard treatment plus the herbal mixture for 10-15 days. Participants in the active group reported significant improvements in recovery time and quality of life scores. The need for antibiotics was on average 2 days shorter for participants taking the complex containing Schisandra.
Posologie
Synergies
Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard--a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever
Fatigue ✪✪✪✪✪
Schisandra is useful in cases of physical fatigue or mental fatigue. The beneficial effect of schisandra on physical activity is thought to be associated with a targeted production and distribution of energy, as well as with combating oxidative stress induced by fatigue through interaction with PGC-1α (transcriptional co-regulators that play a major role in the control of energy and carbohydrate metabolism), but this hypothesis still needs to be verified. A few small studies tend to show its beneficial effect on physical performance, but clinical studies are lacking on this subject.
Posologie
Liver disorders ✪✪✪✪✪
Traditionally, schisandra has been used to treat a variety of liver disorders. Hepatoprotective effects have been observed in in vitro and animal studies; however, the clinical significance of these results in humans remains unknown.
Posologie
Asthma ✪✪✪✪✪
Based on Schisandra's inhibitory effects on leukotriene biosynthesis, its effect on platelet-activating factor, and its anti-inflammatory effects, it is also used for asthma symptoms.
Posologie
Properties
Adaptogen




In Traditional Chinese Medicine, schisandra is considered an adaptogen and is prescribed with other herbs to increase resistance to physical stressors and emotional stressors and to improve allostasis. nnIn animal research, schisandra reduces the increase in heart rate during exercise, resulting in decreased fatigue and improved performance as well as enhanced endurance. The mechanisms of these effects are not yet known. nnPGC-1α, a major regulator of mitochondrial biogenesis, appears to be a candidate for interacting with schisandra to promote more efficient physical exertion, but further studies on this subject are needed. nn
Usages associés
Anti-inflammatory




In vitro, schisandrin inhibits the production of nitric oxide (NO), the release of prostaglandin E2, cyclooxygenase-2 and nuclear factor kappa B (NF-κB). nnIn vitro and in vivo studies have identified anti-inflammatory activity for gomisin A, gomisin J, wuweizi C, schisandrin B, schisandrin C, gomisin N and schisandrin derivatives. Several schisandra lignans, including gomisin N and schisandrol A, have shown potent inhibition of the nuclear factor of activated T cells in vitro. nn
Usages associés
Hepatoprotective




In vitro and in vivo studies have shown hepatoprotective effects with schisandra against carbon tetrachloride toxicity and mercuric chloride toxicity. Research on schisandrin B suggests that it is the main constituent responsible for these beneficial effects. Further investigation reveals that schisandrin B increases the effectiveness of the hepatic glutathione antioxidant system, thereby inhibiting carbon tetrachloride-induced lipid peroxidation. However, additional mechanisms appear likely. More recently, whole Schisandra fruit extract has been shown to induce glutathione S-transferases in vitro. In addition, it has been found that several lignans induce the expression of phase II detoxification enzymes in vitro, a factor considered important in the prevention of liver cancer.
Usages associés
Antioxidant




Seven lignans isolated from Schisandra have shown stronger antioxidant activity than vitamin E at the same concentrations. Schisanhenol appears to have the most significant effects. Schisandra berry essential oil has also demonstrated antioxidant activity.
Anticancer




In vitro, Schisandra extracts and several isolated constituents have demonstrated anticancer activity against various cancer cell lines, including leukemia, breast, liver, stomach, colon, and lung cancers. The mechanisms of action are generally related to the induction of apoptosis, protection of nucleic acids, and the excretion of the carcinogen.
Antiallergic




Schisandra has shown various antiallergic effects, including inhibition of eosinophil recruitment in pulmonary epithelial cells in vitro and a reduction in the severity of atopic dermatitis in vivo. In vivo, schizandrine has shown significant anti-asthmatic activity via inhibition of eosinophil accumulation in the airways, reduction of IL-4, IL-5, interferon-γ and TNF-α levels in bronchoalveolar lavage fluid, reduction of oxidative stress, and inhibition of infiltration of inflammatory cells into lung tissue.
Usages associés
Antihistamine




Schisandra has shown various antiallergic effects, including inhibition of eosinophil recruitment in pulmonary epithelial cells in vitro and a reduction in the severity of atopic dermatitis in vivo. In vivo, schizandrine has shown significant anti-asthmatic activity via inhibition of eosinophil accumulation in the airways, reduction of IL-4, IL-5, interferon-γ and TNF-α levels in bronchoalveolar lavage fluid, reduction of oxidative stress, and inhibition of infiltration of inflammatory cells into lung tissue.
Neurological




Schizandrin and schisandrin B inhibit lipopolysaccharide-induced microglial activation and significantly ameliorate neuronal cell death in vitro and in vivo by inhibiting the microglia-mediated neurotoxic inflammatory response. Microglial activation is involved in the pathophysiology of Alzheimer’s and Parkinson’s diseases. It has also been shown that schisandrin B has a neuroprotective effect in a rat model of transient focal cerebral ischemia and that it improves brain antioxidant status. In vivo, pretreatment with schisandrin B prevented oxidative stress induced by scopolamine (an atropine-like parasympatholytic that acts as a competitive antagonist of acetylcholine) and the impairment of learning and memory. Schisandrin B appears to reduce the acetylcholinesterase activity induced by scopolamine and thus maintain normal acetylcholine levels.
Hypoglycemic




In vitro studies indicate that Schisandra has antidiabetic activity. It was found that various lignans improve basal glucose uptake by hepatic cells, particularly gomisin N. Moreover, in vivo studies show that Schisandra extracts reduce blood glucose, improve lipid metabolism, increase liver glycogen content and polydipsia in diabetic mice. In addition, aqueous Schisandra extracts reduced postprandial blood glucose in rats via inhibition of alpha-glucosidase and alpha-amylase, enzymes responsible for monosaccharide absorption in the small intestine.
Safe dosage
Adults 18 years and older: 1.5 g - 6 g (powder)
There is no typical dosage in clinical research. - Dried fruit: 1.5 to 6 g/day. - Tincture: 15 drops for 25–28 days or 20 to 30 drops, twice a day for 1 month - Infusion: 1.5 g for 150 ml of boiling water, 2 to 3 times a day. Products containing schisandra extract are often standardized to schizandrin components.
Interactions
Médicaments
Cytochrome P450 substrate: moderate interaction
Studies show that schisandra may stimulate or inhibit the activity of the CYP3A4 and CYP2C9 cytochromes. Its action could therefore affect the metabolism of substrates of the P450 cytochromes. An increase in serum levels of drugs mainly metabolized by CYP3A4 is possible. Practitioners are advised to closely monitor patients who are already taking CYP3A4 substrate drugs to avoid adverse effects caused by increased serum drug levels.
Talinolol: moderate interaction
Schisandra increases the bioavailability of talinolol; concomitant use should be monitored.
Phenobarbital: moderate interaction
Schisandra may increase the sedative effects of phenobarbital. Use with caution.
Contraindications
Pregnant women: contraindicated
Available information is insufficient to establish safety.
Breastfeeding: contraindicated
Available information is insufficient to establish safety.
Oral: berries, fruit
270 mg
standardized extract
